SynOx Therapeutics raises 37M in Series A Financing
HealthCap and Medicxi co-lead, joined by Forbion and Gimv
Financing to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumours
DUBLIN, Nov. 19, 2020 -- (Healthcare Sales & Marketing Network) -- SynOx Therapeutics Lt... Biopharmaceuticals, Oncology, Venture Capital SynOx Therapeutics, Celleron Therapeutics, emactuzumab
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news